ResearcherUniversity of British ColumbiaNo recent work listed

Michel Roberge

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2100-0793; OpenAlex author ID A5075759028. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2013: 1 paper

Papers 1

The autophagy inhibitor verteporfin moderately enhances the antitumor activity of gemcitabine in a pancreatic ductal adenocarcinoma model. Last author DOI 10.7150/jca.7030 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Elizabeth Donohue · 1 shared paper, 2013 · strength 0.03
- Paper The autophagy inhibitor verteporfin moderately enhances the antitumor activity of gemcitabine in a pancreatic ductal ad… DOI 10.7150/jca.7030 ↗
Sylvia S. W. Ng · 1 shared paper, 2013 · strength 0.03
- Paper The autophagy inhibitor verteporfin moderately enhances the antitumor activity of gemcitabine in a pancreatic ductal ad… DOI 10.7150/jca.7030 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.